320 related articles for article (PubMed ID: 26412589)
1. Comparative Study of Liver Gene Transfer With AAV Vectors Based on Natural and Engineered AAV Capsids.
Wang L; Bell P; Somanathan S; Wang Q; He Z; Yu H; McMenamin D; Goode T; Calcedo R; Wilson JM
Mol Ther; 2015 Dec; 23(12):1877-87. PubMed ID: 26412589
[TBL] [Abstract][Full Text] [Related]
2. Targeted modifications in adeno-associated virus serotype 8 capsid improves its hepatic gene transfer efficiency in vivo.
Sen D; Gadkari RA; Sudha G; Gabriel N; Kumar YS; Selot R; Samuel R; Rajalingam S; Ramya V; Nair SC; Srinivasan N; Srivastava A; Jayandharan GR
Hum Gene Ther Methods; 2013 Apr; 24(2):104-16. PubMed ID: 23442071
[TBL] [Abstract][Full Text] [Related]
3. Efficient and Targeted Transduction of Nonhuman Primate Liver With Systemically Delivered Optimized AAV3B Vectors.
Li S; Ling C; Zhong L; Li M; Su Q; He R; Tang Q; Greiner DL; Shultz LD; Brehm MA; Flotte TR; Mueller C; Srivastava A; Gao G
Mol Ther; 2015 Dec; 23(12):1867-76. PubMed ID: 26403887
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of engineered AAV capsids for hepatic factor IX gene transfer in murine and canine models.
Markusic DM; Nichols TC; Merricks EP; Palaschak B; Zolotukhin I; Marsic D; Zolotukhin S; Srivastava A; Herzog RW
J Transl Med; 2017 May; 15(1):94. PubMed ID: 28460646
[TBL] [Abstract][Full Text] [Related]
5. Engineered AAV vector minimizes in vivo targeting of transduced hepatocytes by capsid-specific CD8+ T cells.
Martino AT; Basner-Tschakarjan E; Markusic DM; Finn JD; Hinderer C; Zhou S; Ostrov DA; Srivastava A; Ertl HC; Terhorst C; High KA; Mingozzi F; Herzog RW
Blood; 2013 Mar; 121(12):2224-33. PubMed ID: 23325831
[TBL] [Abstract][Full Text] [Related]
6. Application of polyploid adeno-associated virus vectors for transduction enhancement and neutralizing antibody evasion.
Chai Z; Sun J; Rigsbee KM; Wang M; Samulski RJ; Li C
J Control Release; 2017 Sep; 262():348-356. PubMed ID: 28789965
[TBL] [Abstract][Full Text] [Related]
7. Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy.
Gao GP; Alvira MR; Wang L; Calcedo R; Johnston J; Wilson JM
Proc Natl Acad Sci U S A; 2002 Sep; 99(18):11854-9. PubMed ID: 12192090
[TBL] [Abstract][Full Text] [Related]
8. Chimeric Capsid Proteins Impact Transduction Efficiency of Haploid Adeno-Associated Virus Vectors.
Chai Z; Zhang X; Dobbins AL; Frost EA; Samulski RJ; Li C
Viruses; 2019 Dec; 11(12):. PubMed ID: 31835440
[TBL] [Abstract][Full Text] [Related]
9. Rational Design of AAV-rh74, AAV3B, and AAV8 with Limited Liver Targeting.
Chan C; Harris KK; Zolotukhin S; Keeler GD
Viruses; 2023 Oct; 15(11):. PubMed ID: 38005848
[TBL] [Abstract][Full Text] [Related]
10. AAV8 capsid variable regions at the two-fold symmetry axis contribute to high liver transduction by mediating nuclear entry and capsid uncoating.
Tenney RM; Bell CL; Wilson JM
Virology; 2014 Apr; 454-455():227-36. PubMed ID: 24725949
[TBL] [Abstract][Full Text] [Related]
11. Heparin binding directs activation of T cells against adeno-associated virus serotype 2 capsid.
Vandenberghe LH; Wang L; Somanathan S; Zhi Y; Figueredo J; Calcedo R; Sanmiguel J; Desai RA; Chen CS; Johnston J; Grant RL; Gao G; Wilson JM
Nat Med; 2006 Aug; 12(8):967-71. PubMed ID: 16845388
[TBL] [Abstract][Full Text] [Related]
12. Optimized adeno-associated virus (AAV)-protein phosphatase-5 helper viruses for efficient liver transduction by single-stranded AAV vectors: therapeutic expression of factor IX at reduced vector doses.
Jayandharan GR; Zhong L; Sack BK; Rivers AE; Li M; Li B; Herzog RW; Srivastava A
Hum Gene Ther; 2010 Mar; 21(3):271-83. PubMed ID: 19788390
[TBL] [Abstract][Full Text] [Related]
13. Selection and evaluation of clinically relevant AAV variants in a xenograft liver model.
Lisowski L; Dane AP; Chu K; Zhang Y; Cunningham SC; Wilson EM; Nygaard S; Grompe M; Alexander IE; Kay MA
Nature; 2014 Feb; 506(7488):382-6. PubMed ID: 24390344
[TBL] [Abstract][Full Text] [Related]
14. Bioengineered AAV Capsids with Combined High Human Liver Transduction In Vivo and Unique Humoral Seroreactivity.
Paulk NK; Pekrun K; Zhu E; Nygaard S; Li B; Xu J; Chu K; Leborgne C; Dane AP; Haft A; Zhang Y; Zhang F; Morton C; Valentine MB; Davidoff AM; Nathwani AC; Mingozzi F; Grompe M; Alexander IE; Lisowski L; Kay MA
Mol Ther; 2018 Jan; 26(1):289-303. PubMed ID: 29055620
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the relationship of AAV capsid domain swapping to liver transduction efficiency.
Shen X; Storm T; Kay MA
Mol Ther; 2007 Nov; 15(11):1955-62. PubMed ID: 17726459
[TBL] [Abstract][Full Text] [Related]
16. Heparan Sulfate Binding Promotes Accumulation of Intravitreally Delivered Adeno-associated Viral Vectors at the Retina for Enhanced Transduction but Weakly Influences Tropism.
Woodard KT; Liang KJ; Bennett WC; Samulski RJ
J Virol; 2016 Nov; 90(21):9878-9888. PubMed ID: 27558418
[TBL] [Abstract][Full Text] [Related]
17. Autophagy determines efficiency of liver-directed gene therapy with adeno-associated viral vectors.
Hösel M; Huber A; Bohlen S; Lucifora J; Ronzitti G; Puzzo F; Boisgerault F; Hacker UT; Kwanten WJ; Klöting N; Blüher M; Gluschko A; Schramm M; Utermöhlen O; Bloch W; Mingozzi F; Krut O; Büning H
Hepatology; 2017 Jul; 66(1):252-265. PubMed ID: 28318036
[TBL] [Abstract][Full Text] [Related]
18. Characterization of a Bioengineered AAV3B Capsid Variant with Enhanced Hepatocyte Tropism and Immune Evasion.
Rana J; Marsic D; Zou C; Muñoz-Melero M; Li X; Kondratov O; Li N; de Jong YP; Zolotukhin S; Biswas M
Hum Gene Ther; 2023 Apr; 34(7-8):289-302. PubMed ID: 36950804
[TBL] [Abstract][Full Text] [Related]
19. Improved adeno-associated virus (AAV) serotype 1 and 5 vectors for gene therapy.
Sen D; Balakrishnan B; Gabriel N; Agrawal P; Roshini V; Samuel R; Srivastava A; Jayandharan GR
Sci Rep; 2013; 3():1832. PubMed ID: 23665951
[TBL] [Abstract][Full Text] [Related]
20. Age-Related Seroprevalence of Antibodies Against AAV-LK03 in a UK Population Cohort.
Perocheau DP; Cunningham S; Lee J; Antinao Diaz J; Waddington SN; Gilmour K; Eaglestone S; Lisowski L; Thrasher AJ; Alexander IE; Gissen P; Baruteau J
Hum Gene Ther; 2019 Jan; 30(1):79-87. PubMed ID: 30027761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]